Upidosin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUpidosin
Drug Alias Name乌哌多辛upidosinumupidosineupidosinaSB-216469 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRecordati Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecordati Spa
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A